Indeed, CD34+ cells genetically modified to express Shh [CD34+(Shh)] offer a better protection against ventricular dilation and cardiac functional decline than CD34+ cells alone when injected into mice after acute myocardial infarction (80). The gene discussed is SHH; the disease is myocardial infarction.